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Abstract
Background: Minor capsid protein L2 performs an indispensable but uncharacterized role in human papillomavirus
infections. A neutralizing B cell epitope has recently been mapped to the N-terminus of HPV16 L2, residues 17–36, and
exposure of this region of L2 has been implicated in translocation of incoming virions from the endo/lysosomal
compartment to the cellular cytoplasm. Here we examine the redox state of Cys22 and Cys28 two highly conserved
cysteines located within this epitope. We also investigate the infectivity of virions containing L2 single and double cysteine
point mutants.
Methodology and Principal Findings: Denaturing/non-reducing gel analysis and thiol labeling experiments of wild type
and cysteine mutant HPV16 virion particles strongly support the existence of a buried intramolecular C22–C28 disulfide
bond. The disulfide was confirmed by tandem mass spectrometry of L2 protein from non-reduced virions. Single C22S and
C28S and the double C22/28S mutants were non-infectious but had no apparent defects in cell binding, endocytosis, or
trafficking to lysosomes by 8 h post infection. During infection with L2 mutant particles, there was a marked decrease in L2
levels compared to wild type L2-containing virions, suggesting a failure of mutant L2/genome complexes to exit the endo/
lysosomal compartment.
Conclusions and Significance: L2 residues C22 and C28 are bound as an intramolecular disulfide bond in HPV16 virions and
are necessary for infectivity. Previous work has suggested that the furin-dependent exposure of the 17–36 epitope and
subsequent interaction of this region with an unknown receptor is necessary for egress from the endo/lysosomal
compartment and infection. Identification of the C22–C28 disulfide suggests that reduction of this disufide bond may be
necessary for exposure of 17–36 and HPV16 infection.
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Introduction
Human papillomaviruses (HPVs) are small non-enveloped DNA
viruses and are the causative agents of cervical cancer, with HPV
type 16 being responsible for more than 50% of cervical cancers in
women worldwide [1,2]. The HPV16 virion consists of a ,8k b
circular dsDNA genome packaged into a ,60 nm icosahedral
capsid. Initial attachment of HPV16 virions to the host cell
membrane appears to occur via heparan-sulfate proteoglycans
(HSPGs) [3,4]. The capsid is then thought to undergo conforma-
tional changes resulting in transfer to an unknown non-HSPG entry
receptor [5,6]. Additional studies have also implicated direct
binding to the extracellular matrix (ECM) and transfer to the cell
membrane via laminin-5 [7], a process which may also involve
activation of and transfer along cell surface filopodia [8,9]. Cellular
endocytosis of bound HPV16 virions is thought to occur via a
classical clathrin-mediated pathway with trafficking through the
endosomal/lysosomal compartments [10,11]. A recent report
observed HPV16 entry through a clathrin/caveolin-independent
mechanisminvolvingtetraspanin-enriched microdomains, although
this study was done with HeLa cervical carcinoma, 293TT
embryonic kidney, and HuH7 liver cell lines [12]. Regardless of
the mode of entry, trafficking through the acidic endo/lysosomal
pathway appears to be critical for infection of multiple papilloma-
virus (PV) types and the decrease in pH is likely a trigger for virion
uncoating and exit from this compartment [10,13,14].
The capsid is comprised of 72 pentamers of the major capsid
protein L1 and up to 72 molecules of the minor capsid protein L2,
localized along the inner surface of the capsid, within the central
cavities beneath the L1 pentamers [15,16]. Biochemical and
structural studies show that mature virions exist in an oxidized
state with adjacent L1 pentamers crosslinked together by disulfide
bonds, stabilizing the capsid structure [16–20]. The L2 protein is
critical for HPV16 infection [21] and is a multifunctional protein,
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capsid stabilization [24,25], and endosomal escape of virions [13].
L2 protein from incoming particles has been shown to colocalize
with viral genomes and nuclear promyelocytic leukemia protein
(PML) bodies [26], and L2 may function to escort the viral
genome into the host cell nucleus, perhaps through direct
interactions with various nuclear import receptors and the cellular
chaperone Hsc70 [27,28]. L2-dependent localization of viral
genome to PML bodies may serve to promote efficient early gene
expression for the establishment of infection. L2 may also play a
role in late gene expression during HPV infection by directly
binding the viral E2 protein and repressing its transcriptional
activation functions [29,30]. L2-dependent recruitment of E2 and
viral genomes to PML bodies is also postulated to function in
assembly of progeny virions during the late phases of HPV
infection, through sequestration of virion components [31]. L2 has
also been implicated in various interactions with host factors
including cell surface binding [32,33], actin and dynein binding
[34,35] syntaxin 18 binding [36], and cleavage by the cellular
protease furin [37].
The HPV16 L2 protein contains only two cysteines, C22 and
C28. Both are absolutely conserved across all known mammalian
and avian PV types. Recently, L2 residues 17–36 have been
identified as a B-cell epitope that is capable of eliciting a cross-
neutralizing antibody response against a broad variety of HPV
types, making the antigen a promising vaccine candidate [38,39].
Given the position of C22 and C28 within this neutralizing
antibody epitope and the highly oxidized state of mature particles
we sought to examine the redox state of C22 and C28 in HPV16
virions and their role in infectivity. We found that C22 and C28
exist as a buried intramolecular disulfide in mature virions. C22S
and C28S single and C22/28S double mutant virions were non-
infectious but exhibited normal cell binding, uptake, and lysosomal
colocalization at 8 h post infection. Interestingly, the mutant L2
proteins were degraded more rapidly than wild type L2 during the
course of infection. We hypothesize that the cysteine mutants may
be defective for endosomal escape, resulting in lysosomal
degradation of L2/genome complexes wherein infection is
blocked.
Results
Conserved L2 cysteines are not accessible for BMCC-
biotin modification
Sequence alignment of diverse papillomavirus types shows that
C22 and C28 of HPV16 L2 are absolutely conserved throughout
the Family Papillomaviridae (Fig. 1A), prompting us to further
examine the role of these two cysteines in HPV infection. To
examine the native redox state of the two highly conserved L2
cysteines within the structural context of virions, we performed a
thiol-specific biotinylation assay. Purified HPV16 virions were kept
in their native state or reduced by DTT prior to chemical
biotinylation with either amine-specific NHS-biotin or thiol-specific
BMCC-biotin reagents. Biotinylated proteins were then detected by
western blot and streptavidin-HRP staining. NHS-biotin labeling
resulted in robust biotinylation of the amine groups of both L1 and
L2 capsid proteins, irrespective of the redox status of the virions
(Fig. 1B, lanes 1–2). In contrast, L2 was only labeled detectably with
BMCC-biotin ifthevirionswerefirstreduced byDTT(Fig.1B,lane
4). This suggests that within the context of intact particles, C22 and
C28 of HPV16 L2 are either buried and inaccessible to BMCC-
biotin or they are bound up as disulfides, S-nitrosothiols (S-NO), or
some otherS-alkylmodification.Thesepossibilitiesarenot mutually
exclusive, as the cysteines could be both modified and buried.
Characterization of L2 cysteine mutant virions
Single C22S and C28S and the double C22/28S cysteine-to-
serine point mutations were generated in the L2 gene of the
HPV16 capsid expression plasmid. Mutant virions were produced
by transfection of 293TT cells [40,41] and purified by CsCl
density gradient centrifugation as previously described [11].
Virions containing mutant L2 proteins were obtained in yields
comparable to normal HPV16 virions containing wild type L2.
SDS-PAGE and Coomassie staining-based densitometry indicated
that each of the virus preparations contained an average of ,22
molecules L2 per virion (data not shown). Visualization by
transmission electron microscopy revealed normal capsid mor-
phology among all L2 mutant virions (Fig. 2A) and dot blot
analysis showed no decrease in genome encapsidation for any of
Figure 1. Highly conserved HPV16 L2 cysteines C22 and C28 are not reactive with BMCC-biotin in native virions. (A) Primary amino
acid sequence alignment of L2 proteins from various members of the Family Papillomaviridae shows conservation of C22 and C28 (HPV16) across
divergent genera. (B) Amine and thiol biotinylation assays of HPV16 virions. Purified virions were either mock treated (native) or DTT treated (reduced)
prior to incubation with amine reactive NHS-biotin or thiol reactive BMCC-biotin. Biotinylated proteins were separated by SDS-PAGE, transferred to
membranes, and detected with streptavidin-HRP. Note that L2 cysteines are only reactive when the virions are reduced prior to labeling.
doi:10.1371/journal.pone.0004463.g001
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virion preparations for L1 and L2 revealed no defects in L2
encapsidation (Fig. 2B, lanes 5–8). The absence of any size shift in
the L2 mutants suggested that no large modifications (palmitoyla-
tion, prenylation, etc.) were present on the wild type L2 cysteines.
Several possibilities exist regarding the nature of potential disulfide
linkages involving C22 and C28 in the L2 protein. The cysteines
could be linked as intermolecular disulfides to form L2-L2 dimers or
they could be bound as an intramolecular disulfide to form a hairpin-
likestructure. L2couldalsoformadisulfidelinkto L1, whichcontains
twelve cysteine residues. Alternatively, the L2 cysteines could be
bonded to small molecules like glutathione or free cysteine as mixed
disulfides or bound to nitric oxide (NO) as an S-NO group. To
address these possibilities, denaturing SDS-PAGE was performed
under non-reducing conditions to visualize any disulfide-linked
proteins in the virions containing wild type and mutant L2 proteins
(Fig. 2C). L1 was present as high molecular weight multimers in all
the virion preparations (Fig. 2C, lanes 1–4). L2 was present only as
monomers in wild type virions, excluding the possibilities of disulfide
linked L2-L2 dimers or L2-L1 complexes (Fig. 2C, lane 5). As
expectedthedoublemutantwasonlydetectedasamonomer(Fig.2C,
lane 8). Interestingly, the single C22S and C28S mutants were
present mainly as L2 monomers although a small fraction existed as
disulfide linked 150 kDa L2-L2 dimers (Fig. 2C, lanes 6–7). Recent
cryoEM data from Buck et al. suggest a maximum stoichiometry of
one L2 molecule per L1 pentamer or 72 L2 molecules per virion [15].
L2 is therefore present at ,30% occupancy in each of our
preparations, making it likely that the L2-L2 dimers may represent
the small fraction of the total L2 molecules that lie close enough in
space within the 72 L1-pentamer lattice to form intermolecular
disulfide linkages. The absence of intermolecular L2 dimers in wild
type HPV16 virions suggests that C22 and C28 are bound either as
an intramolecular disulfide hairpin or as conjugates to small
molecules, molecular forms that could potentially have the same
migration pattern as reduced L2 in a polyacrylamide gel [42].
However, the L2-L2 dimerization in the C22S and C28S mutant
virions argues that the cysteines are normally present as an
intramolecular disulfide; if they were bound as small molecule mixed
disulfides or S-NO groups, then the single mutants would not be
capable of L2-L2 dimerization because the single remaining cysteine
would still be bound up and unavailable for disulfide linkage.
L2 cysteines are present as an intramolecular disulfide
hairpin
Thiol-specific biotinylation experiments were performed to
further elucidate the nature of HPV16 L2 C22 and C28 residues.
Virions were kept in their native state, reduced by DTT, or
denatured with SDS prior to BMCC-biotin labeling. As seen
previously, L2 molecules from virions in their native state were not
labeled by BMCC-biotin (Fig. 3A) and reduction of virions was
required for L2 biotinylation (Fig. 3B). For the reduced samples, L2
biotinylation was less pronounced for the C22S and C28S mutants
than for virions containing wild type HPV16 L2 proteins (Fig. 3B,
lanes 2–3), presumably because single mutants have only half the
number of cysteines available for BMCC-biotin modification. As
expected,nolabelingwasobserved forthedoubleC22/28Smutant,
which lacks cysteine residues (Fig. 3B, lane 4). If C22 and C28 were
normally bound together as an intramolecular disulfide one might
Figure 2. Characterization of L2 cysteine mutant virions. (A)
Morphology of the L2 wild type and cysteine mutant virions. CsCl-
purified virion preparations were negatively stained and visualized by
transmission electron microscopy. Scale bar represents 100 nm. (B)
Reducing and denaturing SDS-PAGE of wild type and mutant L2-
containing virions, immunoblotted for L1 (left panel) and L2 (right
panel) capsid proteins. Note the absence of L2 size shift for any of the
cysteine mutants, suggesting no large cysteine modifications are
present. (C) Analysis of HPV16 L2 wild type and mutant virions by
denaturing SDS-PAGE under non-reducing conditions. L1 immunoblot
(left panel) shows disulfide-linked multimers of L1 for wild type and
mutant virions. L2 immunoblot (right panel) shows no detectable L2-L2
dimers for wild type or C22/28S virions (lanes 1,4), but a fraction of L2 in
the single cysteine mutants exist as disulfide-linked L2-L2 dimers (lanes
2,3).
doi:10.1371/journal.pone.0004463.g002
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in their native virion states would be free and available to react with
BMCC-biotin. Yet, biotinylation was only observed upon virion
reduction with DTT (Fig. 3A & B, lanes 2–3). Inaccessibility of the
L2 cysteines in native virion paticles could explain this lack of
BMCC-biotin labeling. To determine if C22 and C28 are simply
buried in the context of native virions, virions were denatured with
SDS treatment prior to BMCC-biotin labeling. Only the C22S and
C28S single mutants exhibited robust L2 biotinylation upon
denaturation with SDS, indicating that a majority of the lone
cysteines of the C22S and C28S single mutants exist as free thiols
(Fig. 3C, lanes 2–3). L2 proteins of wild type HPV16 virions were
only minimally labeled after denaturation, suggesting that although
C22and C28areaccessible, they aredisulfidebonded(Fig. 3C,lane
1). Again no labeling was seen for the C22/28S double mutant
because no cysteines are present (Fig. 3C, lane 4).
Tandem mass spectrometry (MS/MS) of non-reduced L2 sample
was performed to verify the existence of the C22–C28 disulfide.
Purified wild type HPV16 virions were reacted with excess N-
ethylmaleimide (NEM) to protect any native disulfide bonds from
reduction by reactive free thiols. Virion proteins were then
separated by denaturing, non-reducing SDS-PAGE and the L2
band was excised for in-gel trypsin digestion and extraction of
tryptic peptides. Trypsin cleavage of L2 is predicted to occur
following lysine residues K20, K23, and K35, within the immediate
vicinity of C22 and C28, in the L2 primary amino acid sequence.
K23 is positioned between C22 and C28, so the disulfide will link
the adjacent T21-K23 and Q24-K35 tryptic peptides. MS analysis
detected masses corresponding to both the doubly and triply
charged cations of the disulfide-bonded peptides (Fig. 4A). MS/MS
of the doubly charged peptide cation and analysis of the internal
fragmentsfurtherverifieditsassignment,confirmingtheexistence of
the C22–C28 disulfide bond in L2 (Fig. 4B).
Infectivity of HPV16 virions containing L2 cysteine
mutants
Papillomavirus virions assembled in the 293TT cell system
retain full infectivity and susceptibility to antibody neutralization
in experimental infections performed both in vitro and in vivo
[11,41,43]. The infectivity of wild type and mutant L2-containing
virions encapsidating HPV16 genomes was assessed on subcon-
fluent HaCaT cells, a spontaneously immortalized keratinocyte
line commonly used to determine HPV infectivity in vitro
[11,44,45]. Total RNA was harvested from infected HaCaT cells
and levels of spliced E1 ˆE4 viral transcripts were quantified by RT-
qPCR, as we have described [11,14,46]. Results showed a .95%
reduction in infectivity for all L2 cysteine mutants (Fig. 5A). To
verify the results were not due to mutant L2 effects on E1 ˆE4
transcription from the viral genome, this experiment was repeated
using wild type and L2 mutant reporter viruses, which encapsidate
a luciferase expression plasmid. Results showed a .99.9%
decrease in luciferase activity (data not shown) verifying that the
L2 cysteine residues are critical for HPV16 virion infectivity.
Binding and trafficking of cysteine mutants
Purified virions were labeled with amine-reactive AlexaFluor
594 (AF594) and cell binding and uptake were assessed by confocal
microscopy. We previously showed that AF594 labeling does not
disrupt HPV particle binding to the extracellular matrix (ECM) or
cell plasma membrane, antibody-mediated neutralization, inter-
nalization time, or infectivity [11]. HaCaT cells were exposed to
AF594-virions for 1 h at 4uC to permit binding but not
internalization. Mutant and wild type virions all displayed normal
ECM and cell membrane binding on HaCaT human keratino-
cytes (data not shown and Fig. 5B, respectively). Previous work has
demonstrated that wild type HPV16 virions enter cells and traffic
to perinuclear lysosomal compartments by 8 h post-infection
[10,11]. Wild type and mutant L2-containing AF594-virions were
analyzed for cell uptake and trafficking by adding fresh media and
shifting the temperature to 37uC for 8 h. Samples were fixed,
permeabilized, and immunostained for LAMP-1, a late endoso-
mal/lysosomal marker [47]. None of the mutants displayed any
defects in entry or colocalization with LAMP-1 (Fig. 5C),
suggesting the infectious block of the cysteine mutants does not
involve cell binding or intracellular trafficking.
Degradation of capsid proteins during intracellular
trafficking
AF594 conjugation results primarily in the labeling of the major
capsid protein L1 due to its high copy number in the virion and
Figure 3. Thiol biotinylation assay of HPV16 L2 cysteine mutants. (A) Lack of L2 biotinylation by BMCC-biotin of normal and mutant virions
in their native state suggest that L2 cysteines are either buried and inaccessible to BMCC-biotin or bound up and not present as free thiols. (B) L2
cysteines become accessible and are biotinylated in DTT-reduced virions. (C) Denaturation of virions by SDS results in L2 biotinylation of C22S and
C28S single mutants only (lanes 2,3), indicative of free but buried cysteines in these mutants. Lack of L2 biotinylation in denatured wild type virions
implies that although the cysteines are exposed, they are bound as an intramolecular disulfide, becoming available for modification in the single
mutants only.
doi:10.1371/journal.pone.0004463.g003
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levels are significantly lower (unpublished observations). The
majority of the AF594 signal in microscopy experiments therefore
is likely to reflect L1, and this signal may persist even if L1 is
proteolytically degraded. To examine the fate of the capsid
proteins during cell entry and trafficking, cells were exposed to
Figure 4. Mass spectrometry of non-reduced L2 protein. (A) The full MS spectra of the L2 tryptic peptides T21-K23 and Q24-K35 with C22–C28
disulfide bond intact. The predominant doubly charged and triply charged parent cations are evident. (B) The MS/MS spectra of the doubly charged
precursor ion and assignment of internal fragments. Upon collisional activation the disulfide bond was broken, but two major non-reduced species
are evident. The non-reduced species were preferentially fragmented at I32 and P34.
doi:10.1371/journal.pone.0004463.g004
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were subjected to immunoblotting for L1 and L2. Known amounts
of purified HPV16 virions were resolved on the gels as a control to
which the intensities of the sample bands on the same blot could
be compared and relative differences in band intensity across
different blots determined. Initial particle binding was equivalent
among the HPV16 wild type and different L2 mutants (Fig. 6A,
lanes 1–5) in agreement with the confocal microscopy data
(Fig. 5B). After 8 h of entry and trafficking, L1 levels dropped to
similar levels among the HPV16 wild type and mutant particles
(Fig. 6A, lanes 6–10), most likely representing degradation of the
protein in the lysosomal compartment, where the majority of L1
colocalizes at 8 h (Fig. 5C). Initial levels of L2 were also
comparable among the different mutants again demonstrating
no defects in L2 levels in the virus particles or in cell binding
(Fig. 6B, lanes 1–5). However, during the course of infection, L2
levels of mutant particles were considerably diminished relative to
those of wild type L2-containing HPV16 virions (Fig. 6B, compare
lane 7 to lanes 8–10). Densitometric comparison of protein levels
relative to the blot-internal loading controls enabled relative
assessment of samples across blots and the percent of capsid
protein remaining after 8 h of intracellular trafficking was
determined for normal HPV16 and each of the mutants. Analysis
showed that ,15–20% of the intact L1 protein remained for each
of the virus infections (Fig. 6C, grey bars). In contrast, L2 levels for
wild type HPV16 virions were ,25–30% of the input quantity
after 8 h of infection, while ,1% of intact L2 proteins remained
for all the cysteine mutants (Fig. 6C, black bars).
Discussion
Minor capsid protein L2 plays a critical role in the early events
of HPV infection although its precise functions in HPV entry,
intracellular trafficking, endosomal escape, and nuclear import of
the HPV genome have not been elucidated. Recently a cross-
neutralizing B-cell epitope has been mapped to residues 17–36 of
HPV16 L2 and RG-1, a monoclonal antibody against this epitope
has been characterized [39]. Here we studied two highly
Figure 5. Infectivity, plasma membrane binding, and trafficking are not obviously affected in HPV16 virions containing L2 cysteine
mutants. (A) HaCaT cells were exposed to normal and mutant virions at an dose of 100 vge/cell. Total RNA was harvested 48 h post infection and
viral E1 ˆE4 transcripts were quantified by RT-qPCR. Results were normalized relative to wild type HPV16 virion infections and presented as mean values
for three replicates6standard deviation. (B) HaCaT cells exposed to AF594-virions (red) for 1 h at 4uC. Unbound virions were washed away prior to
fixation. Nuclei were stained with DAPI (blue) and confocal microscopy was performed with the focal point at the plasma membrane. (C)
Colocalization of AF594-virions with LAMP-1 after 8 h of trafficking. HaCaT cells bound with AF594-virions (red) were allowed to internalize virus for
8 h at 37uC prior to fixation, permeabilization and immunostaining for LAMP-1 (green). Nuclei were stained with DAPI (blue). Scale bars represent
20 mm.
doi:10.1371/journal.pone.0004463.g005
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1 epitope. The redox status of L2 was studied by non-reducing
SDS-PAGE and thiol-specific BMCC-biotin labeling experiments
of HPV16 wild type and L2 cysteine mutant virions. Taken
together, results strongly suggest that C22 and C28 are bonded as
a buried intramolecular disulfide in wild type virions. Mutation of
either C22 or C28 in L2 results in free cysteines that react with
BMCC-biotin when denatured by SDS (Fig. 3C, lanes 2–3). A
small percentage of these C22S or C28S mutant L2 molecules can
actually form L2-L2 dimers through an intermolecular disulfide
(Fig. 2C, lanes 6–7). Wild type L2 can neither form L2-L2 dimers
nor react with BMCC-biotin after SDS-denaturation because C22
and C28 are bound together as a disulfide (Fig. 2C, lane5 & 3C,
lane 1). Consistent with these conclusions, the C22–C28
intramolecular disulfide was directly observed in non-reduced
wild type L2 by tandem MS/MS analysis of polyacrylamide gel
purified protein (Fig. 4).
All L2 cysteine mutant virions were non-infectious despite
exhibiting normal cell binding, internalization, and trafficking to
LAMP-1 positive lysosomes by 8 h post infection (Fig. 5). This
finding is not entirely unexpected since previous work suggests that
HPV16 virus like particles (VLPs), composed entirely of major
capsid protein L1 bind and enter host cells normally, trafficking to
the lysosome [10]. During the first 8 h of infection, we detected
notable differences in the degradation of incoming wild type and
mutant L2 proteins. While L2 levels decreased to ,30% the input
for wild type virions during the first 8 h of infection, levels of
mutant L2 were greatly diminished to less than 1% of input
(Fig. 6C, black bars). The remarkable decrease in mutant L2
protein levels correlates well with the infectivity data (Fig. 5A) and
may reflect the inability of these mutant particles to progress past
the endo/lysosomal compartment. We hypothesize the mutant L2
containing virions bind and enter cells normally, trafficking to the
lysosomal compartment, but the L2/genome complex fails to exit
the lysosome and becomes degraded within this compartment,
thereby abrogating infectivity.
Day et al. recently characterized the mechanisms of RG-1
neutralization, finding that the RG-1 epitope (L2 residues 17–36)
is initially occluded but becomes accessible to RG-1 after a
conformational change occurs on the surface of host cells [48].
Further, they demonstrate that RG-1 epitope exposure is
dependent on cleavage of L2 by the cellular protease furin, a
cleavage event that is essential for infection [37]. The highly
conserved furin cleavage site is positioned at residues R9–R12,
only ten residues upstream of the C22–C28 disulfide. Abrogation
of furin cleavage through either an R9S mutation in L2 or
treatment with the furin inhibitor dec.-RVKR-cmk blocks
infectivity albeit the virions bind and enter cells normally, traffic
and uncoat within the endosomal pathway, but fail to exit the
endo/lysosomal compartment [37]. Therefore, furin-dependent
display of the RG-1 epitope is likely important for endosomal
escape of HPV L2/genome complexes. Our data presented herein
show that in mature virions the RG-1 epitope is hidden in a buried
disulfide-bonded conformation and we hypothesize that exposure
of the epitope may be dependent on reduction of the C22–C28
disulfide, in addition to furin cleavage. Previous work has shown
that the RG-1 antibody is reactive with L2 by western blot [39]
and is therefore likely to only bind L2 17–36 in a reduced
conformation, although this has not formally been examined. Our
findings in the context of those of Day and colleagues [48] suggest
a possible mechanistic connection between furin cleavage and
reduction of L2. However, the temporal sequence of the two
events is currently unclear. One possibility is that a disulfide
bonded structure may be needed for furin cleavage of L2, similar
to what has been shown for HIV gp160 [49,50]. Alternatively,
reduction of the C22–C28 disulfide may be a prerequisite for furin
cleavage. Another possibility is that furin cleavage could precede
and be required for reduction of the disulfide and exposure of the
RG-1 epitope. A similar phenomenon has been shown for
Pseudomonas aeruginosa exotoxin A (PE), a secreted ribotoxin that
enters cells, traffics to the endo/lysosomal compartment and
requires furin cleavage, disulfide reduction, and low pH for
translocation into the cytoplasm [51,52]. In the case of PE, furin
cleavage triggers a conformational change that enables reduction
Figure 6. Degradation of wild type and L2 mutant virions
during infection. Total cell lysates of infected HaCaT cells were
collected at 0 h and 8 h post infection. Lysates were separated by SDS-
PAGE and immunoblotted for capsid proteins. (A) L1 immunoblot of
mock treated and infected HaCaT cell lysate. (B) L2 immunoblot of
mock treated and infected cell lysates. Control lanes contain a known
amount of purified HPV16 for comparison across blots. Asterisks
represent non-specific bands present in cell lysates. (C) Percentages of
L1 (grey bars) and L2 (black bars) capsid proteins remaining after 8 h of
intracellular trafficking was calculated by densitometry as described in
materials and methods.
doi:10.1371/journal.pone.0004463.g006
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or PDI-like enzyme, and subsequent release and cytosolic
translocation of the ribotoxin domain [53]. Notably, we have
observed that HPV16 infection is sensitive to bacitracin (Campos
and Ozbun, unpublished results), an inhibitor of PDI activity [54].
Although PDI-family proteins are largely localized to the
endoplasmic reticulum, recent reports have described a cell
surface localization and function of these enzymes [55–57].
Furthermore, cell surface integrins and ECM components like
fibronectin possess inherent PDI-like enzymatic activity [58,59].
Ultimately the exposure of the 17–36 RG-1 epitope appears to
be necessary for infection, as blocking exposure through inhibition
of furin inhibition prevents exit from the endo/lysosomal
compartment [37]. Interestingly an overlapping region of L2,
residues 13–31, has been shown to bind to an unknown receptor
on the surface of SiHa, CaSki, and HeLa cervical epithelial cells
[33]. Thus it seems that the host cell receptor for the RG-1 epitope
is a cell surface protein, although binding of L2 to this unknown
host factor is only important for egress of genome/L2 from the
endo/lysosomal compartment and not for virion uptake. The 13–
31 peptide likely binds to cells in a reduced form, as these studies
were performed with peptide-GFP-GST fusions purified on
immobilized glutathione and eluted with reduced glutathione [33].
Further, 13–31 peptide binding was blocked through a valine
double point mutation of residues 21 and 22 (T21V, C22V),
suggesting that the free thiol group from the reduced C22 residue
may directly interact with the unknown receptor. From our data
we cannot ascertain whether the defect observed for the L2
cysteine mutants comes from the lack of the C22–C28 disulfide
structure or whether it is a consequence of a failed interaction/
binding between the exposed RG-1 epitope and an unknown host
receptor due to the replacement of cysteines with serines. The high
conservation of the RG-1 epitope and C22/C28 among HPV
types (Fig. 1A) may be a result of selective pressures to both
maintain the binding/interaction capabilities necessary for
endosomal escape as well as to conceal this region from immune
surveillance in the form of a disulfide bonded structure. Masking of
antigenic epitopes by disulfides has been described for other
viruses [60,61]. The identification of the C22–C28 disulfide
described herein warrants further experimentation to reveal the
relationships between disulfide reduction, furin cleavage, exposure
of the 17–36 epitope, and HPV16 infection.
Materials and Methods
Cell culture and infections
293TT cells (kindly provided by Chris Buck, NCI) were
maintained in DMEM High Glucose (Irvine Scientific) supple-
mented with 10% FBS, antibiotic/antimycotic (Invitrogen), and
0.4 mg/ml Hygromycin B (Roche). HaCaT cells (a gift of N.
Fusenig, DKFZ), an immortalized human keratinocyte line [44]
were maintained in DMEM/Ham’s F-12 medium (Irvine
Scientific), supplemented with 10% FBS (Invitrogen), 46 amino
acids (Invitrogen), and glutamine-penicillin-streptomycin (Invitro-
gen). For infections HaCaT cells were seeded in 12-well plates at
2610
5 cells per well. Virion stocks were vortexed and diluted to
6.67610
7 viral genome equivalents (vge) per ml HaCaT media.
Viral inocula were added to HaCaT cells (300 ml at 100 vge per
cell) and incubated at 4uC for 1 h with gentle rocking to permit
viral attachment. Inocula were aspirated, cells were washed with
media, and fresh media were added. Infections were allowed to
proceed at 37uC for 48 h. Total RNAs were extracted from cells
using TRIreagent (Invitrogen), and nucleic acid concentrations
were determined by spectrophotometery. Reverse transcription
(RT) of 2 mg total RNA and triplicate quantitative PCR (qPCR)
reactions were performed using GeneAmp RNA PCR reagents
and AmpliTaq Gold DNA polymerase (Applied Biosystems) using
qPCR primers, probes, and conditions as previously described
[11,45,46].
Virion production, purification, and fluor-labeling
HPV16 virions were generated in 293TT cells as previously
described [11,41]. Briefly, 293TT cells, plated to ,70% confluence
in 10 cm dishes were CaPO4 cotransfected with 15 mg each
pXULL (L1 and L2 expression plasmid) and the cloned HPV16
genome that had been excised from pBS-HPV16 and recircularized
by T4 DNA ligase. Luciferase reporter transducing virions were
produced by cotransfection of 293TT cells with 15 mge a c ho f
pXULL and pGL3-control (Promega). Cells were harvested 48 h
post transfection by trypsinization and pelleted/resuspended in
PBS+9.5 mM MgCl2 at 100 ml/10 cm plate. Cells were lysed by
the addition of Brij58 to 0.35%. Unpackaged DNA was digested by
adding exonuclease V (Epicentre plasmid-safe) to 20 U/ml and
Benzonase (Sigma) to 0.3%. Lysates were then incubated overnight
at 37uC for maturation [17], after which 0.17 volumes of 5 M NaCl
was added and lysates were 36 freeze/thawed at 280/37uCt o
further break apart cellular structures. Lysates were cleared by
centrifugation at 30006g and supernatants were loaded onto
discontinuous CsCl gradients made from 4 ml light (1.25 g/ml)
CsCl underlaid with 4 ml heavy (1.4 g/ml) CsCl. Virions were
purified by 18 h ultracentrifugation at 20,000 rpm and 4uCi na
Sorvall TH-641 rotor/buckets. Viral bands were visible slightly
above the gradient interface and were collected by side puncture
with a 1.5’’ 18 gauge needle and 5 ml syringe. Virions were washed
36 and concentrated in HSB (25 mM HEPES pH 7.5, 0.5 M
NaCl, 1 mM MgCl2) using Amicon Ultra-4 100,000 MWCO
centrifugation filter units (Millipore) and stored at 280uC. Purity
and L1 protein content were determined by SDS-PAGE and
Coomassie Brilliant Blue staining against bovine serum albumin
(BSA) standards. Virion morphology and quality was visualized by
negative staining with 2% uranyl acetate and transmission electron
microscopy(TEM;Hitachi7500)at 80 kVfollowingadsorption to a
carbon-coated electron microscopy grid. Viral genome equivalent
(vge) titers were determined by dot blot hybridization as previously
described [45,46]. For fluorophore labeling, ,5 mg of HPV16
virions was diluted into 200 ml HSB and labeled with 500 ng
AlexaFluor 594 (AF594) carboxylic acid succinimidyl ester
(Molecular Probes) in the dark for 45 min at room temperature.
Excess dye was removed by washing 36and resuspending in 100 ml
HSB using Amicon Ultra-4 100,000 kDa MWCO centrifugation
filter units (Millipore). AF594-virions were stored at 280uC in HSB.
Creation of L2 mutants
pXULL variants encoding the single C22S and C28S mutants
as well as the double C22/28S mutant were generated by site
directed mutagenesis using the QuikChange II XL system
(Stratagene). Mutant pXULL plasmids were verified by sequence
analysis and used to generate infectious virions in 293TT cells as
described above.
Sequence alignment
L2 sequences were obtained from the NCBI protein database.
Accession numbers are as follows: AAD33258 (HPV16, genus
alpha, species 9), AAA46955 (HPV31, genus alpha, species 9),
P22165 (RhPV1, rhesus papillomavirus type 1, genus alpha,
species 12), P04013 (HPV11, genus alpha, species 10), AAY86493
(HPV45, genus alpha, species 7), AAY86491 (HPV5, genus beta,
species 1), NP_056743 (BPV1, bovine papillomavirus type 1,
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papillomavirus, genus kappa), AAL14230 (FcPV, Fringilla coelebs,
finch papillomavirus, genus eta). Genus and species assignments
are based on recently reported phylogeny [62]. The indicated L2
residues were aligned with the MacVector software ClustalW
algorithm using the BLOSUM series matrix with default settings
for open gap penalty, extended gap penalty, delay divergent
percentage, and protein gap parameters.
Polyacrylamide gel electrophoresis (PAGE)
For reducing/denaturing PAGE, HPV16 virions (diluted to
8 ng/ml in HSB) were mixed with an equal volume of reducing/
denaturing SDS-PAGE loading buffer (62.5 mM Tris pH 6.8,
10% glycerol, 2% SDS, 0.05% 2-mercaptoethanol, 0.05%
bromophenol blue) and heated to 95uC for 5 min prior to
electrophoresis on 10% polyacrylamide gels. For non-reducing/
denaturing PAGE, HPV16 samples were diluted as above into
HSB containing 2 mM N-ethylmaleimide (NEM, Sigma) and
reacted for 1.5 h at room temperature. The purpose of the NEM
reaction is to inactivate free thiols (cysteines) prior to denaturation,
thereby preventing reduction of any native disulfide bonds by
these free thiols during denaturation. Samples were then mixed
with an equal volume of non-reducing/denaturing SDS-PAGE
loading buffer (62.5 mM Tris pH 6.8, 10% glycerol, 2% SDS,
0.05% bromophenol blue) and incubated at room temperature for
10 min prior to electrophoresis on 7.5% polyacrylamide gels.
Samples were transferred to PVDF membranes and L1 and L2
capsid proteins were detected by probing with 1:10,000 dilutions
of anti-[HPV16 L1] monoclonal antibody (Abcam #30908) and
1:7500 dilutions of anti-[HPV31 L2] polyclonal antisera
(DK43811, kindly provided by Richard Roden, Johns Hopkins)
with 1:25,000 dilutions of the appropriate HRP-conjugated
secondary. HRP signal was detected with SuperSignal West Pico
chemiluminescent substrate (Thermo Scientific).
Thiol biotinylation assays
HPV16 virions (1 mg L1) were incubated overnight at room
temperature in either 200 ml HSB (native), HSB+10 mM
dithiothreitol (DTT; reduced). Samples were loaded onto Amicon
Ultra-4 5,000 MWCO centrifugation filter units (Millipore) and
washed 36 and resuspended in 120 ml HSB. Biotinylation
reactions were then set up using 20 ml of native or DTT-reduced
virion sample and 1 mg of either amine-reactive biotinyl-N-
hydroxysuccinimide ester (NHS-biotin, Sigma) or thiol-reactive
1-biotinamido-4-[49-(maleimidomethyl)cyclohexanecarboxamido]
butane (BMCC-biotin, Thermo Scientific). Samples were biotiny-
lated for 30 min at 37uC and stopped by the addition of 10 ml
denaturing/reducing SDS-PAGE loading buffer (containing Tris
and 2-ME to quench amine/thiol reactive reagents). Samples were
denatured at 95uC for 5 min and 10 ml aliquots were electropho-
resed on 7.5% polyacrylamide gels and transferred to PVDF
membranes for detection of biotinylated proteins by probing with
streptavidin-HRP. SDS denaturation experiments were performed
by diluting HPV16 virions (500 ng L1) into 50 mlH S B +1% SDS
and 1 mg BMCC-biotin. Samples were reacted for 1 h at 37uCa nd
processed as described above.
Mass spectrometry
Purified HPV16 virions (23 mgL 1i n4 0ml HSB) were reacted
with 5 mM NEM for 2 h at room temperature and mixed with
10 ml denaturing/non-reducing SDS-PAGE loading buffer, and
separated on a 7.5% gel as described above. The gel was briefly
stained with Biosafe Coomassie (Biorad) to visualize L1 and L2
bands. The L2 protein band (about 2 mg total L2 protein) was
excised and in-gel tryptic digestion was done as previously
reported [63]. The digest was done in the presence of a mass
spectrometry friendly surfactant (Protease Max, Promega) to
provide increased sequence coverage and the reduction and
alkylation steps were excluded. Extracted peptides were dried to
completion and reconstituted to 8 ml in 0.1% formic acid, 2%
acetonitrile, water. Nano reversed phase HPLC was done using a
2D nanoLC (Eksigent) with buffer A consisting of 0.1% (v/v)
formic acid in water and buffer B 0.1% formic acid in acetonitrile.
A fused silica column self packed with duragel C18 matrix (Peeke
Scientific) was used with a linear gradient from 5% B to 40% B
over 60 minutes at a flow rate of 450 nl/min. The nanoHPLC was
interfaced with a nanomate (Advion Biosciences) for nanoESI into
the mass spectrometer. The mass spectrometer was a LCQ Deca
XP Plus (Thermo Scientific) that was set in data dependent
acquisition mode to perform MS/MS on the top three most
intense ions with a dynamic exclusion setting of four. The DTA
files were extracted from the raw data using the bioworks browser
(Thermo Scientific). The data were searched against the NCBI
Virus database using Mascot, as well as against the late minor
capsid protein L2 (gi 4927726) sequence using SEQUEST
(Thermo Scientific).
Virion binding and entry assays
HaCaT cells were sparsely seeded on sterile glass coverslips and
grown for 1.5 days. Cells were prechilled to 4uC for 15 min, media
were aspirated and ,200–300 ng AF594 labeled virus was bound
to cells for 1 h at 4uC. For binding assays, unbound virus was
aspirated and cells were washed once with PBS and fixed in
PBS+2% paraformaldehyde for 10 min at room temperature.
Cells were washed 36with PBS and coverslips were mounted on
glass slides with VectashieldH plus 49,6-diamidino-2-phenylindole
(DAPI, Vector Laboratories). Coverslips were sealed with nail
polish and stored at 4uC. Entry studies were set up as described
above but after AF594-virion binding cells were washed once with
warm media and transferred to 37uC for 8 h. Cells were then
washed 26with PBS, fixed/permeabilized in ice-cold acetone for
10 min at 220uC, washed 36with PBS at room temperature, and
blocked overnight in PBS with 4% BSA and 0.4% goat serum.
The blocking solution was aspirated and cells were incubated in
mouse anti-[LAMP-1] (Abcam #25630) diluted 1:100 in 10%
blocking solution for 1 h at room temperature. Cells were washed
56 PBS and incubated in AF680-labeled goat anti-[mouse]
(Molecular Probes) diluted 1:200 to [10 ng/ml] for 1 h at room
temperature. Cells were then washed 56with PBS and mounted
in VectashieldH plus DAPI (Vector Laboratories). Slides were
visualized on a Zeiss LSM 510-META confocal microscope with a
636 objective. DAPI, AF594, and AF680 signals were detected
with 405 nm laser diode, HeNe1 laser (543 nm), and HeNe2 laser
(633 nm) excitations respectively. Images were acquired with the
Zeiss LSM software and processed with Adobe Photoshop and
Microsoft Powerpoint software. AF680 signal (LAMP-1 immuno-
staining) was pseudocolored green for contrast of co-localization
with virions.
Measurement of capsid protein levels during infection
HaCaT cells were seeded at 2610
5 cells/well in 12-well plates.
The following day, cells were exposed to 1.25 mg purified virions
in 500 ml media for 1 h at 4uC or mock infected. Cells were
washed twice with media to remove unbound virus and either
lysed (for 0 h time point) or replaced with fresh media and
incubated at 37uC for an additional 8 h. Cell lysates were
prepared by direct addition of 200 ml SDS-PAGE loading buffer
to the cell monolayers. Lysates were clarified of genomic DNA by
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to 95uC for 5 min prior to separation on a 7.5% polyacrylamide
gel. Cell lysate (15 ml) was analyzed for L1 immunoblots and 30 ml
of the lysate was analyzed for L2 immunodetection. Control lanes
contained known amounts of HPV16 virions; 31 ng of L1
(9.5610
8 particles) for L1 blots and 62 ng of L1 (1.9610
9
particles) for L2 blots. Gels were transferred to PVDF membranes
and blocked overnight at 4uC in TBST plus 2% dried milk, 2%
BSA, and 1% goat serum. Blots were probed for L1 and L2
proteins as described above. Films were scanned on a BioRad GS-
800 densitometer and analyzed with Quantity One software
(BioRad). Mean densities were determined for the samples relative
to the internal loading control band and percent capsid protein
remaining after 8 h was calculated for L1 and L2.
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